A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localised prostate cancer
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference23 articles.
1. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association;Barry;J Urol,1992
2. Biochemical and disease free survival following iodine 125 prostate implantation;Beyer;Int J Radiat Oncol Biol Phys,1997
3. Health related quality of life in men receiving prostate brachytherapy on RTOG 98-05;Feigenberg;Int J Radiat Oncol Biol Phys,2005
4. Urinary morbidity following ultrasound guided transperineal prostate seed implantation;Gelblum;Int J Radiat Oncol Biol Phys,1999
5. Ten-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy;Grimm;Int J Radiat Oncol Biol Phys,2001
Cited by 68 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Redefining bladder neck dose in low-dose-rate prostate brachytherapy–Can we improve urinary toxicity without impacting disease control?;Brachytherapy;2024-01
2. Relationship between changes in quality of life and genitourinary toxicity grade after brachytherapy with I-125 alone for localised prostate cancer;Reports of Practical Oncology and Radiotherapy;2023-04-06
3. Permanent interstitial low-dose-rate brachytherapy for prostate cancer: institutional experience with implementation and predictive factors for outcome and side effects;Journal of Radiotherapy in Practice;2023
4. PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot study;Brachytherapy;2021-11
5. Comparison of disease‐specific quality of life in prostate cancer patients treated with low‐dose‐rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil;International Journal of Urology;2021-08-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3